Berg, Belgium

Michel Joseph Maurice André Guillaume


 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Berg, BE (2006 - 2013)
  • Steenokkerzeel, BE (2013)

Company Filing History:


Years Active: 2006-2013

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Michel Joseph Maurice André Guillaume

Introduction

Michel Joseph Maurice André Guillaume is a notable inventor located in Berg, Belgium. With a remarkable portfolio of five patents, Guillaume has made significant contributions to the field of pharmaceutical science, primarily enhancing treatment methodologies for various disorders. His work reflects a dedication to innovation that aligns closely with industry needs.

Latest Patents

Guillaume's latest inventions demonstrate his forward-thinking approach and technical expertise. One of his significant patents details a "Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide," a novel procedure suitable for industrial use. This invention describes how N-lidocaine can be synthesized by reacting piperazine with N-haloacetyl-2,6-xylidine through a series of steps from a to f.

Additionally, he has developed patents concerning "Nalmefene prodrugs." This invention outlines ester prodrugs of nalmefene, along with pharmaceutical compositions and chemical processes for their preparation. These compounds show promise in the treatment of substance abuse disorders such as alcohol dependence and impulse control disorders, including pathological gambling and shopping addiction.

Career Highlights

Michel Guillaume currently works at Janssen Pharmaceutica NV, a leading company in pharmaceutical innovation. His role has positioned him at the forefront of drug development, allowing him to contribute to significant advancements in medicine.

Collaborations

Throughout his career, Guillaume has collaborated with esteemed colleagues, including Yolande Lydia Lang and Stefan Marcel Herman Leurs. These partnerships have fostered a creative environment, enabling innovative research and the successful development of breakthrough technologies that address public health challenges.

Conclusion

Michel Joseph Maurice André Guillaume exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to improving treatment methods through invention continues to make a positive impact on society. As he progresses in his career, his contributions will undoubtedly influence the future of medical science, reflecting the vital role that inventors play in shaping health care advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…